RNA Binding Proteins As Regulators of Oxidative Stress Identified by a Targeted CRISPR-Cas9 Single Guide RNA Library.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Turner DJ;Turner DJ; Turner M; Turner M
  • Source:
    The CRISPR journal [CRISPR J] 2021 Jun; Vol. 4 (3), pp. 427-437. Date of Electronic Publication: 2021 Jun 04.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101738191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-1602 (Electronic) Linking ISSN: 25731599 NLM ISO Abbreviation: CRISPR J Subsets: MEDLINE
    • Publication Information:
      Original Publication: [New Rochelle, NY] : Mary Ann Liebert, Inc., [2018]-
    • Subject Terms:
    • Abstract:
      The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 genome editing system has been broadly adopted for high-throughput genetic screens. However, the application of genome-wide single guide RNA (sgRNA) libraries can be challenging. We generated a custom sgRNA library, an order of magnitude smaller than genome-wide alternatives, to facilitate the genetic screening of RNA binding proteins (RBPs). We demonstrated the utility of our reagent in a genetic screen for RBPs that conveyed cellular resistance or sensitivity to oxidative stress induced by paraquat. This identified that CSDE1 and STRAP, proteins that interact with each other, convey sensitivity to oxidative stress and that Pumilio homologues (PUM1 and PUM2) convey resistance. Targeting eIF4-E1 and -A1 protected cells from high-dose paraquat, whereas eIF4E2 targeted cells did less well. We also found that G3BP1 promoted sensitivity to a low dose of paraquat but protected cells at a higher dose. Our study highlights the use of genetic screens to identify roles of RBPs and identifies novel genes regulating sensitivity to oxidative stress.
    • References:
      Mol Cell. 2017 Nov 16;68(4):808-820.e5. (PMID: 29129640)
      Cell. 2016 Jan 14;164(1-2):69-80. (PMID: 26724866)
      Nat Rev Genet. 2014 Dec;15(12):829-45. (PMID: 25365966)
      Mol Cell. 2012 Jun 8;46(5):674-90. (PMID: 22681889)
      Genome Biol. 2010;11(10):R106. (PMID: 20979621)
      Mol Biol Rep. 2020 Jan;47(1):785-807. (PMID: 31643042)
      Sci Rep. 2018 Feb 8;8(1):2628. (PMID: 29422612)
      J Biol Chem. 2008 Jan 25;283(4):1786-98. (PMID: 18039652)
      Cell. 2015 Mar 12;160(6):1246-60. (PMID: 25748654)
      World Allergy Organ J. 2012 Jan;5(1):9-19. (PMID: 23268465)
      Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2734-2739. (PMID: 29483269)
      Cell. 2005 Apr 22;121(2):281-93. (PMID: 15851034)
      J Cell Biol. 2003 Mar 17;160(6):823-31. (PMID: 12642610)
      J Cell Sci. 2020 Sep 1;133(16):. (PMID: 32873715)
      PLoS One. 2018 Aug 23;13(8):e0201690. (PMID: 30138317)
      Cell Rep. 2020 Feb 4;30(5):1417-1433.e7. (PMID: 32023459)
      Trends Genet. 2018 Dec;34(12):972-990. (PMID: 30316580)
      Nat Biotechnol. 2016 Feb;34(2):184-191. (PMID: 26780180)
      Nat Rev Microbiol. 2004 Oct;2(10):820-32. (PMID: 15378046)
      EMBO Rep. 2016 Oct;17(10):1374-1395. (PMID: 27629041)
      Mol Cell Biol. 2012 Sep;32(17):3585-93. (PMID: 22751931)
      Nature. 2019 Dec;576(7787):471-476. (PMID: 31827283)
      Genes Dev. 1999 Feb 15;13(4):437-48. (PMID: 10049359)
      Cancer Cell. 2016 Nov 14;30(5):694-707. (PMID: 27908735)
      Nat Commun. 2015 Dec 03;6:10127. (PMID: 26632259)
      Genome Biol. 2014;15(12):554. (PMID: 25476604)
      Elife. 2019 Feb 08;8:. (PMID: 30735131)
      Environ Health Perspect. 1984 Apr;55:37-46. (PMID: 6329674)
      Mol Cell Biol. 2013 Feb;33(4):815-29. (PMID: 23230274)
      J Cell Biol. 2016 Mar 28;212(7):845-60. (PMID: 27022092)
      Cell. 2020 Apr 30;181(3):716-727.e11. (PMID: 32259488)
      Nucleic Acids Res. 2014 Jan;42(2):1026-41. (PMID: 24163252)
      Nat Chem Biol. 2017 Dec;13(12):1274-1279. (PMID: 29058724)
      Cell. 2012 Jun 8;149(6):1393-406. (PMID: 22658674)
      Nat Immunol. 2002 Dec;3(12):1129-34. (PMID: 12447370)
      Cell. 2020 Feb 6;180(3):411-426.e16. (PMID: 31928844)
      Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16419-24. (PMID: 15534200)
    • Grant Information:
      BBS/E/B/000C0407 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; 200823/Z/16/Z United Kingdom WT_ Wellcome Trust
    • Accession Number:
      0 (EIF4E2 protein, human)
      0 (Eukaryotic Initiation Factor-4E)
      0 (PUM1 protein, human)
      0 (PUM2 protein, human)
      0 (Poly-ADP-Ribose Binding Proteins)
      0 (RNA Recognition Motif Proteins)
      0 (RNA, Guide, CRISPR-Cas Systems)
      0 (RNA-Binding Proteins)
      EC 3.6.4.- (DNA Helicases)
      EC 3.6.4.12 (G3BP1 protein, human)
      EC 3.6.4.13 (RNA Helicases)
    • Publication Date:
      Date Created: 20210607 Date Completed: 20211221 Latest Revision: 20240306
    • Publication Date:
      20240306
    • Accession Number:
      PMC8236562
    • Accession Number:
      10.1089/crispr.2020.0116
    • Accession Number:
      34096786